BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1397740)

  • 1. Helicobacter pylori, peptic ulcer disease and inhibition of gastric acid secretion.
    Rune S
    Digestion; 1992; 51 Suppl 1():11-6. PubMed ID: 1397740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antral Helicobacter pylori infection, hypergastrinemia and peptic ulcers: effect of eradicating the organism.
    Park SM; Yoo BC; Lee HR; Yoon JH; Cha YJ
    Korean J Intern Med; 1993 Jan; 8(1):19-24. PubMed ID: 8268142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients.
    Tari A; Hamada M; Kamiyasu T; Sumii K; Haruma K; Inoue M; Kishimoto S; Kajiyama G; Walsh JH
    Dig Dis Sci; 1997 Aug; 42(8):1741-6. PubMed ID: 9286243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of acid inhibition in the treatment of Helicobacter pylori infection.
    Axon AT
    Scand J Gastroenterol Suppl; 1994; 201():16-23. PubMed ID: 8047818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hp and pH--the relevance of gastric acid to the treatment of Helicobacter pylori infection.
    Hunt RH
    J Gastroenterol; 1994 Jul; 29 Suppl 7():128-33. PubMed ID: 7921145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment.
    el-Nujumi A; Williams C; Ardill JE; Oien K; McColl KE
    Gut; 1998 Feb; 42(2):159-65. PubMed ID: 9536937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effectiveness of omeprazole, azithromycin and amoxicillin in ulcer healing and eradication of Helicobacter pylori infection].
    Gribajcević M; Vanis N; Mesihović R
    Med Arh; 2003; 57(1 Suppl 2):107-10. PubMed ID: 15137249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J; Börsch G
    Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
    Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
    Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Helicobacter pylori and gastric acid secretion].
    Konturek JW; Domschke W
    Z Gastroenterol; 1999 Feb; 37(2):187-94. PubMed ID: 10190251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
    Yang KC; Wang GM; Chen JH; Chen TJ; Lee SC
    J Formos Med Assoc; 2003 Dec; 102(12):857-62. PubMed ID: 14976565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).
    Gabryelewicz A; Laszewicz W; Dzieniszewski J; Ciok J; Marlicz K; Bielecki D; Popiela T; Legutko J; Knapik Z; Poniewierka E
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():93-105. PubMed ID: 9440060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
    Gisbert JP; Hermida C; Pajares JM
    Hepatogastroenterology; 2001; 48(41):1383-8. PubMed ID: 11677970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causal role of Helicobacter pylori in peptic ulcer relapse.
    Asaka M; Ohtaki T; Kato M; Kudo M; Kimura T; Meguro T; Horita S; Inoue K
    J Gastroenterol; 1994 Jul; 29 Suppl 7():134-8. PubMed ID: 7921146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Helicobacter pylori on parietal cell sensitivity to pentagastrin in duodenal ulcer subjects.
    Chittajallu RS; Howie CA; McColl KE
    Scand J Gastroenterol; 1992 Oct; 27(10):857-62. PubMed ID: 1439539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.